Biotechnology News Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-10 out of 10 found

Current Search:

Sanofi Pasteur inaugurates High Tech vaccine production facility to respond to soaring demand worldwide
Sanofi Pasteur inaugurates High Tech vaccine production facility to respond to soaring demand worldwide.

Aventis: Jun 27 2008 11:43AM

Find similar documents

U.S. FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel
FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel.

Aventis: Jun 23 2008 8:45AM

Find similar documents

Sanofi-aventis becomes a major partner in the biotechnology field in year leading to BIO 2008
With nine major agreements concluded in the last twelve months , sanofi -aventis is a partner of choice to develop molecules & vaccines for the future San Diego, California - June 17, 2008 - Sanofi -aventis announced today at the...

Aventis: Jun 20 2008 5:19AM

Find similar documents

Sanofi-aventis intends to make a Competing Bid of CzK 1,050 in cash per share for Zentiva
This is a public announcement by sanofi-aventis pursuant to the provisions of the Czech Republic's Act No.

104/2008 Coll., on Takeover Bids, as amended.

This announcement does not constitute an offer for ordinary shares and/or global...

Aventis: Jun 20 2008 5:19AM

Find similar documents

Sanofi Pasteur to donate 60 million doses of H5N1 vaccine to WHO over 3 years for its influenza vaccine global
Press release Sanofi Pasteur Lyon, France and Swiftwater, USA, June 16, 2008 Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today its commitment to donate 60 million doses of H5N1 vaccine to the World Health...

Aventis: Jun 16 2008 1:08PM

Find similar documents

Acomplia (rimonabant) significantly improved glucose control in type 2 diabetes patients treated with insulin
Acomplia (rimonabant) significantly improved glucose control in type 2 diabetes patients treated with insulin.

Aventis: Jun 11 2008 4:19AM

Find similar documents

Insulin Glulisine APIDRA efficacy in the treatment of children and adolescents with type 1 diabetes
Abstract 1791-P Insulin Glulisine A RA efficacy in the treatment of children and adolescents with type 1 diabetes - A new study comparing efficacy and safety of A RA and insulin Lispro as part of a basal -bolus regimen Paris, France June 7,...

Aventis: Jun 8 2008 4:03AM

Find similar documents

Sanofi-aventis and Oxford BioMedica report encouraging Trovax Phase II trial results in metastatic renal canc
Sanofi-aventis and Oxford BioMedica report encouraging Trovax Phase II trial results in metastatic renal canc.

Aventis: Jun 5 2008 12:11AM

Find similar documents

Sanofi-aventis and Oxford Biomedica Report Encouraging Trovax Phase II Trial Results in Metastatic Renal Canc
Sanofi-aventis and Oxford Biomedica Report Encouraging Trovax Phase II Trial Results in Metastatic Renal Canc.

Aventis: Jun 3 2008 4:26AM

Find similar documents

Node-negative early stage breast cancer patients benefit from Taxotere-based chemotherapy
Node-negative early stage breast cancer patients benefit from Taxotere-based chemotherapy.

Aventis: May 27 2008 2:22PM

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.